ALLMedicine™ Malignant Hypertension Center
Research & Reviews 190 results
https://doi.org/10.1097/HJH.0000000000003357
Journal of Hypertension; Boulestreau R, Lorthioir A et. al.
Feb 1st, 2023 - Malignant hypertension has not disappeared and is associated with a poor prognosis. Yet, so far, it has received limited attention from the medical community. Guidelines are mainly based on expert consensus and low quality evidences. We set up a p...
https://doi.org/10.1038/s41371-022-00779-6
Journal of Human Hypertension; Tillement J, Lucas L et. al.
Dec 11th, 2022 - Is headache at admission associated with higher rate of recent brain MRI injury during malignant hypertension crisis?|2022|Tillement J,Lucas L,Cremer A,Gosse P,Doublet J,|
https://doi.org/10.1093/ndt/gfac324
Nephrology, Dialysis, Transplantation : Official Publicat... Bureau C, Jamme M et. al.
Dec 9th, 2022 - Nephrosclerosis is one of the histopathological consequences of severe or malignant hypertension (MH), some of the pathophysiology for which has been extrapolated from essential polygenetic arterial hypertension. Despite our recent description of ...
https://doi.org/10.1016/j.jcjo.2022.11.009
Canadian Journal of Ophthalmology. Journal Canadien D'oph... Basilious A, McInnis RL et. al.
Dec 9th, 2022 - Malignant hypertension causing severe chorioretinopathy.|2022|Basilious A,McInnis RL,Juncal VR,|
https://doi.org/10.1111/bcp.15631
British Journal of Clinical Pharmacology; Mrabet S, Dahmane R et. al.
Dec 9th, 2022 - Interferon-beta (IFNβ), the most widely prescribed medication for multiple sclerosis, is generally considered safe. Nevertheless, rare serious and/or life-threatening side effects have been reported such as thrombotic microangiopathy. A few mechan...
Drugs 4 results see all →
Clinicaltrials.gov 16 results
https://clinicaltrials.gov/ct2/show/NCT03755726
Aug 31st, 2022 - Malignant hypertension is the most severe form of high blood pressure, fatal if left untreated. It has not disappeared, with an increasing incidence. Patients with the disease, mainly young (35 to 55 years of age), have an unfavorable cardiovascul...
https://clinicaltrials.gov/ct2/show/NCT05308823
Apr 4th, 2022 - Participants The study will include group of patients with an established diagnosis of idiopathic intracranial hypertenton meeting our inclusion criteria and will admitted to Al-Azher Univerity Hospitals (Al-Hussien and Bab El-Shaeria) after infor...
https://clinicaltrials.gov/ct2/show/NCT04991077
Mar 24th, 2022 - The pathophysiology of malignant hypertension is poorly understood. The current dogma is based on an overwhelming renin-angiotensin-aldosterone system activation, leading to arterial hypertension that overcomes target organ auto-regulatory mechani...
https://clinicaltrials.gov/ct2/show/NCT01810744
Mar 15th, 2019 - The treatment of the most common cancers (colon, breast, lung, liver and kidney) has recently added a new therapeutic class known as the "anti-angiogenic". It was born from a better understanding of tumor growth requires the development of neo-ves...
https://clinicaltrials.gov/ct2/show/NCT03479060
Jun 6th, 2018 - In literature, Cupping therapy(CT) has been shown to be used mostly for pain control and the majority of RCT studies have shown that CT has potential benefits in pain conditions. Previous studies have reported the effect of pain mediator substance...
News 23 results
https://www.onclive.com/view/targeted-therapies-safer-for-heart-than-anthracyclines
Dec 20th, 2020 - Michael S. Ewer, MD Concerns about cardiotoxicity of molecularly targeted anticancer therapies may be overblown, according to Michael S. Ewer, MD, from The University of Texas MD Anderson Cancer Center in Houston. Although molecularly targeted ag...
https://www.medscape.com/viewarticle/880994
Jun 2nd, 2017 - NEW YORK (Reuters Health) - Emergency department physicians should check certain patients for optic nerve head edema (ONHE) by fundus photography, researchers say. "The FOTO-ED study showed that non-mydriatic retinal photography in the emergency d...
https://www.mdedge.com/rheumatology/article/136018/thrombosis/new-diagnostic-tool-identifies-severe-adamts13-deficiency
Mary Ann Moon
Apr 18th, 2017 - Researchers have developed and validated a new diagnostic tool – the PLASMIC score – that rapidly predicts severe ADAMTS13 deficiency in patients who present with thrombotic microangiopathy, effectively distinguishing those who have thrombotic thr.
https://reference.medscape.com/viewarticle/877078_2
Mar 13th, 2017 - Malignant hypertension and accelerated hypertension are both hypertensive emergencies, with similar outcomes and therapies. Accelerated hypertension is defined as a recent significant increase over baseline blood pressure that is associated with t...
https://reference.medscape.com/viewarticle/877078
Mar 13th, 2017 - Each week, we publish a new Fast Five Quiz focused on a specific clinical topic. We compiled the toughest questions into a cardiology challenge round. Tens of thousands of your colleagues answered, but less than half were able to correctly identif...